The nCounter Vantage 3D Assays enable simultaneous detection of DNA, RNA, and protein changes in a single assay to use less precious material and gather more informative data. Based on the proven nCounter digital molecular barcoding technology, this approach removes potential bias amplification and simplifies analysis by comparing genotype and gene and protein expression in a single view. For product information, configurations, and lists of targets, visit Immune Assays and Solid Tumor Assays.
Application Deadline: January 31, 2017
Grant Recipient Notification: February 15, 2017
Description: Please submit the following:
Award: Four submissions will be awarded reagents selected above to profile 36 samples using their desired nCounter Vantage 3D Assays. Winning submissions will be selected by NanoString in its sole discretion.
Award Shipment Date: This panel will be shipped in 2017.
Restrictions: M.D.s are not eligible to apply for this grant.
Terms & Conditions: By submitting your application, you agree that NanoString may use your name, abstract title, abstract and your submitted quote for marketing purposes.
FOR RESEARCH USE ONLY. Not for use in diagnostic procedures.